Results 251 to 260 of about 234,795 (273)

Cyclosporine for Plaque-Type Psoriasis — Results of a Multidose, Double-Blind Trial

New England Journal of Medicine, 1991
Charles N Ellis, Kevin D Cooper
exaly  

TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis

Expert Review of Clinical Immunology, 2020
Giovanna Malara, Giampiero Girolomoni, Luca Bianchi   +2 more
exaly  

Methotrexate versus Cyclosporine in Moderate-to-Severe Chronic Plaque Psoriasis

New England Journal of Medicine, 2003
Menno de Rie, Brent Cornelis Opmeer, Phyllis Spuls   +2 more
exaly  

Efalizumab therapy in plaque psoriasis

Current Rheumatology Reports, 2004
openaire   +2 more sources

Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study

Circulation, 2017
Heather L Teague, Jonathan H Chung, Veit Sandfort   +2 more
exaly  

Brodalumab in the treatment of chronic plaque psoriasis

Expert Opinion on Biological Therapy, 2020
Giampiero Girolomoni, Paolo Gisondi
exaly  

A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis

New England Journal of Medicine, 2015
Kristian Reich, Bruce Randazzo
exaly  

Etanercept Treatment for Children and Adolescents with Plaque Psoriasis

New England Journal of Medicine, 2008
Amy S. Paller, Lawrence F Eichenfield, Elaine C Siegfried   +2 more
exaly  

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

New England Journal of Medicine, 2017
Jean-Philippe Lacour, Howard Sofen, Melinda Gooderham   +2 more
exaly  

Liposomal fusidic acid as a potential delivery system: a new paradigm in the treatment of chronic plaque psoriasis

Drug Delivery, 2016
Kaisar Raza, Gajanand Sharma, OP Katare
exaly